↓ Skip to main content

Dove Medical Press

Article Metrics

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

Overview of attention for article published in OncoTargets and therapy, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
9 patents

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
64 Mendeley
Title
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
Published in
OncoTargets and therapy, September 2014
DOI 10.2147/ott.s49187
Pubmed ID
Authors

Massimo Offidani, Laura Corvatta, Patrizia Caraffa, Silvia Gentili, Laura Maracci, Pietro Leoni

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
United States 1 2%
Colombia 1 2%
Unknown 61 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 17%
Researcher 11 17%
Student > Bachelor 10 16%
Other 7 11%
Student > Postgraduate 6 9%
Other 15 23%
Unknown 4 6%
Readers by discipline Count As %
Medicine and Dentistry 21 33%
Agricultural and Biological Sciences 15 23%
Biochemistry, Genetics and Molecular Biology 9 14%
Chemistry 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 6 9%
Unknown 6 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2020.
All research outputs
#5,418,935
of 16,904,817 outputs
Outputs from OncoTargets and therapy
#273
of 2,424 outputs
Outputs of similar age
#101,195
of 275,404 outputs
Outputs of similar age from OncoTargets and therapy
#8
of 47 outputs
Altmetric has tracked 16,904,817 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,424 research outputs from this source. They receive a mean Attention Score of 2.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.